Cargando…

Accuracy of a Novel SARS-CoV-2 Antigen-Detecting Rapid Diagnostic Test from Standardized Self-Collected Anterior Nasal Swabs

Background Antigen-detecting rapid diagnostic tests (Ag-RDT) for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) offer new opportunities for the quick and laboratory-independent identification of infected individuals for control of the SARS-CoV-2 pandemic. Despite the potential benefits...

Descripción completa

Detalles Bibliográficos
Autores principales: Osmanodja, Bilgin, Budde, Klemens, Zickler, Daniel, Naik, Marcel G., Hofmann, Jörg, Gertler, Maximilian, Hülso, Claudia, Rössig, Heike, Horn, Philipp, Seybold, Joachim, Lunow, Stephanie, Bothmann, Melanie, Barrera-Pesek, Astrid, Mayrdorfer, Manuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8153114/
https://www.ncbi.nlm.nih.gov/pubmed/34068236
http://dx.doi.org/10.3390/jcm10102099
_version_ 1783698729744728064
author Osmanodja, Bilgin
Budde, Klemens
Zickler, Daniel
Naik, Marcel G.
Hofmann, Jörg
Gertler, Maximilian
Hülso, Claudia
Rössig, Heike
Horn, Philipp
Seybold, Joachim
Lunow, Stephanie
Bothmann, Melanie
Barrera-Pesek, Astrid
Mayrdorfer, Manuel
author_facet Osmanodja, Bilgin
Budde, Klemens
Zickler, Daniel
Naik, Marcel G.
Hofmann, Jörg
Gertler, Maximilian
Hülso, Claudia
Rössig, Heike
Horn, Philipp
Seybold, Joachim
Lunow, Stephanie
Bothmann, Melanie
Barrera-Pesek, Astrid
Mayrdorfer, Manuel
author_sort Osmanodja, Bilgin
collection PubMed
description Background Antigen-detecting rapid diagnostic tests (Ag-RDT) for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) offer new opportunities for the quick and laboratory-independent identification of infected individuals for control of the SARS-CoV-2 pandemic. Despite the potential benefits, nasopharyngeal sample collection is frequently perceived as uncomfortable by patients and requires trained healthcare personnel with protective equipment. Therefore, anterior nasal self-sampling is increasingly recognized as a valuable alternative. Methods We performed a prospective, single-center, point of care validation of an Ag-RDT using a polypropylene absorbent collector for standardized self-collected anterior nasal swabs. Real-time polymerase chain reaction (RT-PCR) from combined oropharyngeal/nasopharyngeal swabs served as a comparator. Primary endpoint was sensitivity of the standardized Ag-RDT in symptomatic patients with medium or high viral concentration (≥1 million RNA copies on RT-PCR for SARS-CoV-2). Results Between 12 February and 22 March 2021, 388 participants were enrolled. After exclusion of 9 patients for which no PCR result could be obtained, the novel Ag-RDT was evaluated based on 379 participants, of whom 273 were symptomatic and 106 asymptomatic. In 61 samples from symptomatic patients with medium or high viral load (≥1 million RNA copies), the sensitivity of the standardized Ag-RDT was 96.7% (59/61; 95% confidence interval (CI): 88.7–99.6%) for the primary endpoint. In total, 62 positive Ag-RDT results were detected out of 70 RT-PCR positive individuals, yielding an overall sensitivity of 88.6% (95% CI: 78.7–94.9%). Specificity was 99.7% (95% CI: 98.2–100%) in 309 RT-PCR negative individuals. Conclusions Here, we present a validation of a novel Ag-RDT with a standardized sampling process for anterior nasal self-collection, which meets World Health Organisation (WHO) criteria of ≥80% sensitivity and ≥97% specificity. Although less sensitive than RT-PCR, this assay could be beneficial due to its rapid results, ease of use, and suitability for standardized self-testing.
format Online
Article
Text
id pubmed-8153114
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-81531142021-05-27 Accuracy of a Novel SARS-CoV-2 Antigen-Detecting Rapid Diagnostic Test from Standardized Self-Collected Anterior Nasal Swabs Osmanodja, Bilgin Budde, Klemens Zickler, Daniel Naik, Marcel G. Hofmann, Jörg Gertler, Maximilian Hülso, Claudia Rössig, Heike Horn, Philipp Seybold, Joachim Lunow, Stephanie Bothmann, Melanie Barrera-Pesek, Astrid Mayrdorfer, Manuel J Clin Med Article Background Antigen-detecting rapid diagnostic tests (Ag-RDT) for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) offer new opportunities for the quick and laboratory-independent identification of infected individuals for control of the SARS-CoV-2 pandemic. Despite the potential benefits, nasopharyngeal sample collection is frequently perceived as uncomfortable by patients and requires trained healthcare personnel with protective equipment. Therefore, anterior nasal self-sampling is increasingly recognized as a valuable alternative. Methods We performed a prospective, single-center, point of care validation of an Ag-RDT using a polypropylene absorbent collector for standardized self-collected anterior nasal swabs. Real-time polymerase chain reaction (RT-PCR) from combined oropharyngeal/nasopharyngeal swabs served as a comparator. Primary endpoint was sensitivity of the standardized Ag-RDT in symptomatic patients with medium or high viral concentration (≥1 million RNA copies on RT-PCR for SARS-CoV-2). Results Between 12 February and 22 March 2021, 388 participants were enrolled. After exclusion of 9 patients for which no PCR result could be obtained, the novel Ag-RDT was evaluated based on 379 participants, of whom 273 were symptomatic and 106 asymptomatic. In 61 samples from symptomatic patients with medium or high viral load (≥1 million RNA copies), the sensitivity of the standardized Ag-RDT was 96.7% (59/61; 95% confidence interval (CI): 88.7–99.6%) for the primary endpoint. In total, 62 positive Ag-RDT results were detected out of 70 RT-PCR positive individuals, yielding an overall sensitivity of 88.6% (95% CI: 78.7–94.9%). Specificity was 99.7% (95% CI: 98.2–100%) in 309 RT-PCR negative individuals. Conclusions Here, we present a validation of a novel Ag-RDT with a standardized sampling process for anterior nasal self-collection, which meets World Health Organisation (WHO) criteria of ≥80% sensitivity and ≥97% specificity. Although less sensitive than RT-PCR, this assay could be beneficial due to its rapid results, ease of use, and suitability for standardized self-testing. MDPI 2021-05-13 /pmc/articles/PMC8153114/ /pubmed/34068236 http://dx.doi.org/10.3390/jcm10102099 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Osmanodja, Bilgin
Budde, Klemens
Zickler, Daniel
Naik, Marcel G.
Hofmann, Jörg
Gertler, Maximilian
Hülso, Claudia
Rössig, Heike
Horn, Philipp
Seybold, Joachim
Lunow, Stephanie
Bothmann, Melanie
Barrera-Pesek, Astrid
Mayrdorfer, Manuel
Accuracy of a Novel SARS-CoV-2 Antigen-Detecting Rapid Diagnostic Test from Standardized Self-Collected Anterior Nasal Swabs
title Accuracy of a Novel SARS-CoV-2 Antigen-Detecting Rapid Diagnostic Test from Standardized Self-Collected Anterior Nasal Swabs
title_full Accuracy of a Novel SARS-CoV-2 Antigen-Detecting Rapid Diagnostic Test from Standardized Self-Collected Anterior Nasal Swabs
title_fullStr Accuracy of a Novel SARS-CoV-2 Antigen-Detecting Rapid Diagnostic Test from Standardized Self-Collected Anterior Nasal Swabs
title_full_unstemmed Accuracy of a Novel SARS-CoV-2 Antigen-Detecting Rapid Diagnostic Test from Standardized Self-Collected Anterior Nasal Swabs
title_short Accuracy of a Novel SARS-CoV-2 Antigen-Detecting Rapid Diagnostic Test from Standardized Self-Collected Anterior Nasal Swabs
title_sort accuracy of a novel sars-cov-2 antigen-detecting rapid diagnostic test from standardized self-collected anterior nasal swabs
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8153114/
https://www.ncbi.nlm.nih.gov/pubmed/34068236
http://dx.doi.org/10.3390/jcm10102099
work_keys_str_mv AT osmanodjabilgin accuracyofanovelsarscov2antigendetectingrapiddiagnostictestfromstandardizedselfcollectedanteriornasalswabs
AT buddeklemens accuracyofanovelsarscov2antigendetectingrapiddiagnostictestfromstandardizedselfcollectedanteriornasalswabs
AT zicklerdaniel accuracyofanovelsarscov2antigendetectingrapiddiagnostictestfromstandardizedselfcollectedanteriornasalswabs
AT naikmarcelg accuracyofanovelsarscov2antigendetectingrapiddiagnostictestfromstandardizedselfcollectedanteriornasalswabs
AT hofmannjorg accuracyofanovelsarscov2antigendetectingrapiddiagnostictestfromstandardizedselfcollectedanteriornasalswabs
AT gertlermaximilian accuracyofanovelsarscov2antigendetectingrapiddiagnostictestfromstandardizedselfcollectedanteriornasalswabs
AT hulsoclaudia accuracyofanovelsarscov2antigendetectingrapiddiagnostictestfromstandardizedselfcollectedanteriornasalswabs
AT rossigheike accuracyofanovelsarscov2antigendetectingrapiddiagnostictestfromstandardizedselfcollectedanteriornasalswabs
AT hornphilipp accuracyofanovelsarscov2antigendetectingrapiddiagnostictestfromstandardizedselfcollectedanteriornasalswabs
AT seyboldjoachim accuracyofanovelsarscov2antigendetectingrapiddiagnostictestfromstandardizedselfcollectedanteriornasalswabs
AT lunowstephanie accuracyofanovelsarscov2antigendetectingrapiddiagnostictestfromstandardizedselfcollectedanteriornasalswabs
AT bothmannmelanie accuracyofanovelsarscov2antigendetectingrapiddiagnostictestfromstandardizedselfcollectedanteriornasalswabs
AT barrerapesekastrid accuracyofanovelsarscov2antigendetectingrapiddiagnostictestfromstandardizedselfcollectedanteriornasalswabs
AT mayrdorfermanuel accuracyofanovelsarscov2antigendetectingrapiddiagnostictestfromstandardizedselfcollectedanteriornasalswabs